Literature DB >> 15265802

Indomethacin potentiates acetylcholine-induced vasodilation by increasing free radical production.

Antonella De Angelis1, Barbara Rinaldi, Annalisa Capuano, Francesco Rossi, Amelia Filippelli.   

Abstract

We studied the effects of indomethacin on endothelium-dependent and -independent vascular relaxation in rat thoracic aortic rings and its role in superoxide anion (O(2)(-)) production. We measured isometric force changes in response to acetylcholine (Ach, 1 nM-0.1 mM), sodium nitroprusside (SNP, 0.1 nM-0.1 microM; a nitric oxide (NO) donor) and cromakalim (1 nM-0.1 mM; a K(ATP)-channel opener) in aorta rings contracted with norepinephrine (NE, 0.1 microM). Indomethacin (10 microM; 20 min) significantly increased Ach-induced vasodilation (EC(50) decreased from 8.99 microM to 16 nM). The free radical scavengers superoxide dismutase and 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl completely reverted these effects. Indomethacin did not affect SNP- or cromakalim-induced vasodilation. Neither acetylsalicylic acid (ASA, 5-100 microM; 15 min) nor ketoprofen (1-100 microM; 15 min) affected Ach, SNP and cromakalim concentration-response curves. Incubation of the aorta with Ach (1 microM) rapidly and markedly increased intracellular NO fluorescence in the aorta endothelium. Indomethacin did not affect Ach-induced NO production. We measured intracellular O(2)(-) in the aorta endothelium with dihydroethidium (DHE) dye. Indomethacin significantly increased O(2)(-) fluorescence versus controls. Neither ASA nor ketoprofen affected O(2)(-) fluorescence. Nitrotyrosine staining was increased in indomethacin-treated aorta sections exposed to Ach, which indicates endogenous formation of peroxynitrite. It was low in aorta sections exposed to Ach alone or with ASA or ketoprofen. We cannot judge if indomethacin-induced endothelium-dependent vasodilation damages or protects the cardiovascular system. Here, we show that indomethacin acts on the cardiovascular system regardless of cyclooxygenase inhibition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15265802      PMCID: PMC1575185          DOI: 10.1038/sj.bjp.0705877

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

Review 1.  NAD(P)H oxidases and their relevance to atherosclerosis.

Authors:  D Sorescu; K Szöcs; K K Griendling
Journal:  Trends Cardiovasc Med       Date:  2001 Apr-May       Impact factor: 6.677

Review 2.  The cardiovascular effects and implications of peroxynitrite.

Authors:  R S Ronson; M Nakamura; J Vinten-Johansen
Journal:  Cardiovasc Res       Date:  1999-10       Impact factor: 10.787

3.  In vitro study of the antioxidant properties of non steroidal anti-inflammatory drugs by chemiluminescence and electron spin resonance (ESR).

Authors:  A M Mouithys-Mickalad; S X Zheng; G P Deby-Dupont; C M Deby; M M Lamy; J Y Reginster; Y E Henrotin
Journal:  Free Radic Res       Date:  2000-11

4.  Oxidative stress, mitochondrial function, and acute glutamate excitotoxicity in cultured cerebellar granule cells.

Authors:  R F Castilho; M W Ward; D G Nicholls
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

5.  Isoprostanes in atherosclerosis.

Authors:  A Oguogho; H Sinzinger
Journal:  J Physiol Pharmacol       Date:  2000-12       Impact factor: 3.011

6.  The protective role of nitric oxide in the brain ischemia.

Authors:  L W Dobrucki; L Kalinowski; W Uracz; T Malinski
Journal:  J Physiol Pharmacol       Date:  2000-12       Impact factor: 3.011

Review 7.  Oxidative stress and vascular damage in hypertension.

Authors:  C Berry; M J Brosnan; J Fennell; C A Hamilton; A F Dominiczak
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-03       Impact factor: 2.894

Review 8.  Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure.

Authors:  Dan Sorescu; Kathy K Griendling
Journal:  Congest Heart Fail       Date:  2002 May-Jun

Review 9.  Free radicals in the physiological control of cell function.

Authors:  Wulf Dröge
Journal:  Physiol Rev       Date:  2002-01       Impact factor: 37.312

Review 10.  Antioxidants and endothelial dysfunction in hyperlipidemia.

Authors:  A Warnholtz; H Mollnau; M Oelze; M Wendt; T Münzel
Journal:  Curr Hypertens Rep       Date:  2001-02       Impact factor: 5.369

View more
  5 in total

Review 1.  Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth.

Authors:  Jacek Zielonka; B Kalyanaraman
Journal:  Free Radic Biol Med       Date:  2010-01-29       Impact factor: 7.376

2.  Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction.

Authors:  Donato Cappetta; Grazia Esposito; Raffaele Coppini; Elena Piegari; Rosa Russo; Loreta Pia Ciuffreda; Alessia Rivellino; Lorenzo Santini; Concetta Rafaniello; Cristina Scavone; Francesco Rossi; Liberato Berrino; Konrad Urbanek; Antonella De Angelis
Journal:  Br J Pharmacol       Date:  2017-05-16       Impact factor: 8.739

3.  Cyclooxygenase-dependent mechanisms mediate in part the anti-dilatory effects of perivascular adipose tissue in uterine arteries from pregnant rats.

Authors:  Oluwatobiloba Osikoya; Spencer C Cushen; Contessa A Ricci; Styliani Goulopoulou
Journal:  Pharmacol Res       Date:  2021-07-24       Impact factor: 10.334

4.  Nitric oxide pathway-mediated relaxant effect of aqueous sesame leaves extract (Sesamum radiatum Schum. & Thonn.) in the guinea-pig isolated aorta smooth muscle.

Authors:  André B Konan; Jacques Y Datté; Paul A Yapo
Journal:  BMC Complement Altern Med       Date:  2008-05-27       Impact factor: 3.659

5.  Glycolaldehyde-modified proteins cause adverse functional and structural aortic remodeling leading to cardiac pressure overload.

Authors:  Dorien Deluyker; Virginie Bito; Sibren Haesen; Ümare Cöl; Wouter Schurgers; Lize Evens; Maxim Verboven; Ronald B Driesen; Annelies Bronckaers; Ivo Lambrichts
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.